GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Arch Biopartners Inc (OTCPK:ACHFF) » Definitions » Cash Receipts from Securities Related Activities

ACHFF (Arch Biopartners) Cash Receipts from Securities Related Activities


View and export this data going back to 1999. Start your Free Trial

What is Arch Biopartners Cash Receipts from Securities Related Activities?

Cash Receipts from Securities Related Activities only applies to banks.


Arch Biopartners Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Arch Biopartners Inc (OTCPK:ACHFF) » Definitions » Cash Receipts from Securities Related Activities
Traded in Other Exchanges
Address
545 King Street West, Toronto, ON, CAN, M5V 1M1
Arch Biopartners Inc is a late-stage clinical trial company focused on preventing acute kidney injury and organ damage caused by inflammation. The company is developing a platform of novel drugs that target the dipeptidase-1 (DPEP1) inflammation pathway, which is prevalent in the kidneys, lungs, and liver.